azd5069
Showing 1 - 11 of 11
Metastatic Castration Resistant Prostate Cancer Trial in Switzerland, United Kingdom (AZD5069, Enzalutamide 40 MG)
Active, not recruiting
- Metastatic Castration Resistant Prostate Cancer
- AZD5069
- Enzalutamide 40 MG
-
Bellinzona, Switzerland
- +3 more
Mar 18, 2022
Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (AZD9150, MEDI4736, AZD5069)
Active, not recruiting
- Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck
- AZD9150
- +3 more
-
Birmingham, Alabama
- +42 more
Oct 3, 2022
Bronchiectasis, Lung Disease, Respiratory Diseases Trial in Czech Republic, Poland, United Kingdom (AZD5069, Placebo)
Completed
- Bronchiectasis
- +2 more
- AZD5069
- Placebo
-
Ostrava, Czech Republic
- +14 more
Sep 7, 2015
COPD Trial in London (AZD5069)
Completed
- Chronic Obstructive Pulmonary Disease
- AZD5069
-
London, United KingdomResearch Site
Jun 24, 2015
Healthy Trial in Nottingham (AZD5069, Placebo)
Completed
- Healthy
- AZD5069
- Placebo
-
Nottingham, United KingdomResearch Site
Jun 24, 2015
Healthy Trial in Croydon (AZD5069, Placebo)
Completed
- Healthy
- AZD5069
- Placebo
-
Croydon, United KingdomResearch Site
Jun 24, 2015
Healthy Trial in London Bridge (AZD5069, Placebo)
Completed
- Healthy
- AZD5069
- Placebo
-
London Bridge, United KingdomResearch Site
Jun 24, 2015
COPD (COPD). Trial in London (AZD4721, Placebo, AZD5069)
Completed
- Chronic Obstructive Pulmonary Disease (COPD).
- AZD4721
- +2 more
-
London, United KingdomResearch Site
Jun 24, 2015